Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Inherited Metabolic Disease
Published in: Journal of Inherited Metabolic Disease 3/2017

Open Access 01-05-2017 | Review

Sweet and sour: an update on classic galactosemia

Authors: Ana I. Coelho, M. Estela Rubio-Gozalbo, João B. Vicente, Isabel Rivera

Published in: Journal of Inherited Metabolic Disease | Issue 3/2017

Login to get access

Abstract

Classic galactosemia is a rare inherited disorder of galactose metabolism caused by deficient activity of galactose-1-phosphate uridylyltransferase (GALT), the second enzyme of the Leloir pathway. It presents in the newborn period as a life-threatening disease, whose clinical picture can be resolved by a galactose-restricted diet. The dietary treatment proves, however, insufficient in preventing severe long-term complications, such as cognitive, social and reproductive impairments. Classic galactosemia represents a heavy burden on patients’ and their families’ lives. After its first description in 1908 and despite intense research in the past century, the exact pathogenic mechanisms underlying galactosemia are still not fully understood. Recently, new important insights on molecular and cellular aspects of galactosemia have been gained, and should open new avenues for the development of novel therapeutic strategies. Moreover, an international galactosemia network has been established, which shall act as a platform for expertise and research in galactosemia. Herein are reviewed some of the latest developments in clinical practice and research findings on classic galactosemia, an enigmatic disorder with many unanswered questions warranting dedicated research.
Literature
Anonymous (1982) Clouds over galactosaemia. Lancet 2:1379–1380
Antshel KM, Epstein IO, Waisbren SE (2004) Cognitive strengths and weaknesses in children and adolescents homozygous for the galactosemia Q188R mutation: a descriptive study. Neuropsychology 18:658–664PubMedCrossRef
Ashino J, Okano Y, Suyama I et al (1995) Molecular characterization of galactosemia (Type 1) mutations in Japanese. Hum Mutat 6:36–43PubMedCrossRef
Batey LA, Welt CK, Rohr F et al (2013) Skeletal health in adult patients with classic galactosemia. Osteoporos Int 24:501–509PubMedCrossRef
Belman AL, Moshe SL, Zimmerman RD (1986) Computed tomographic demonstration of cerebral edema in a child with galactosemia. Pediatrics 78:606–609PubMed
Berry GT (1995) The role of polyols in the pathophysiology of hypergalactosemia. Eur J Pediatr 154:S53–S64PubMedCrossRef
Berry GT, Walter JH (2012) Disorders of galactose metabolism. In: Saudubray JM, van den Berghe G, Walter JH (eds) Inborn metabolic diseases: diagnosis and treatment. Springer, Heidelberg
Berry GT, Palmieri M, Gross KC et al (1993) The effect of dietary fruits and vegetables on urinary galactitol excretion in galactose-1-phosphate uridyltransferase deficiency. J Inherit Metab Dis 16:91–100PubMedCrossRef
Berry GT, Nissim I, Gibson JB et al (1997) Quantitative assessment of whole body galactose metabolism in galactosemic patients. Eur J Pediatr 156:S43–S49PubMedCrossRef
Berry GT, Hunter JV, Wang Z et al (2001) In vivo evidence of brain galactitol accumulation in an infant with galactosemia and encephalopathy. J Pediatr 138:260–262PubMedCrossRef
Berry GT, Moate PJ, Reynolds RA et al (2004) The rate of de novo galactose synthesis in patients with galactose-1-phosphate uridyltransferase deficiency. Mol Genet Metab 81:22–30PubMedCrossRef
Bhat PJ (2003) Galactose-1-phosphate is a regulator of inositol monophosphatase: a fact or a fiction? Med Hypotheses 60:123–128PubMedCrossRef
Bhat M, Haase C, Lee PJ (2005) Social outcome in treated individuals with inherited metabolic disorders: UK study. J Inherit Metab Dis 28:825–830PubMedCrossRef
Bosch AM, Bakker HD, Van Gennip AH, Van Kempen JV, Wanders RJA, Wijburg FA (2003) Clinical features of galactokinase deficiency: a review of the literature. J Inherit Metab Dis 25:629–634CrossRef
Bosch AM, Bakker HD, Wenniger-Prick LJ, Wanders RJ, Wijburg FA (2004a) High tolerance for oral galactose in classical galactosaemia: dietary implications. Arch Dis Child 89:1034–1036PubMedPubMedCentralCrossRef
Bosch AM, Grootenhuis MA, Bakker HD, Heijmans HSA, Wijburg FA, Last BF (2004b) Living with classical galactosemia: health-related quality of life consequences. Pediatrics 113:e423–e428PubMedCrossRef
Bosch AM, Maurice-Stam H, Wijburg FA, Grootenhuis MA (2009) Remarkable differences: the course of life of young adults with galactosaemia and PKU. J Inherit Metab Dis 32:706–712PubMedCrossRef
Briones P, Giros M, Martinez V (2001) Second spontaneous pregnancy in a galactosaemic woman homozygous for the Q188R mutation. JIMD 24:79–80
Calderon FR, Phansalkar AR, Crockett DK, Miller M, Mao R (2007) Mutation database for the galactose-1-phosphate uridyltransferase (GALT) gene. Hum Mutat 28:939–943PubMedCrossRef
Carney AE, Sanders RD, Garza KR et al (2009) Origins, distribution and expression of the Duarte-2 (D2) allele of galactose-1-phosphate uridylyltransferase. Hum Mol Genet 18:1624–1632PubMedPubMedCentralCrossRef
Charlwood J, Clayton P, Keir G, Mian N, Winchester B (1998) Defective galactosylation of serum transferrin in galactosemia. Glycobiology 8:351–357PubMedCrossRef
Chen J, Yager C, Reynolds R, Palmieri M, Segal S (2002a) Erythrocyte galactose 1-phosphate quantified by isotope-dilution gas chromatography–mass spectrometry. Clin Chem 48:604–612PubMed
Chen J, Yager CT, Reynolds RA, Segal S (2002b) Identification of galactitol and galactonate in red blood cells by gas chromatography/mass spectrometry. Clin Chim Acta 322:37–41PubMedCrossRef
Clarke JTR (2005) Newborn screening. A clinical guide to inherited metabolic diseases. Cambridge University Press, Cambridge, pp 228–240CrossRef
Coelho AI, Ramos R, Gaspar A et al (2014a) A frequent splicing mutation and novel missense mutations color the updated mutational spectrum of classic galactosemia in Portugal. J Inherit Metab Dis 37:43–52PubMedCrossRef
Coelho AI, Trabuco M, Ramos R et al (2014b) Functional and structural impact of the most prevalent missense mutations in classic galactosemia. Mol Genet Genomic Med 2:484–496PubMedPubMedCentralCrossRef
Coelho AI, Trabuco M, Silva M et al (2015a) Arginine functionally improves clinically relevant human galactose-1-phosphate uridylyltransferase (GALT) variants expressed in a prokaryotic model. J Inherit Metab Dis Rep 23:1–6
Coelho AI, Berry GT, Rubio-Gozalbo ME (2015b) Galactose metabolism and health. Curr Opin Clin Nutr Metab Care 18:422–427PubMedCrossRef
Coelho AI, Lourenco S, Trabuco M et al (2015c) Functional correction by antisense therapy of a splicing mutation in the GALT gene. Eur J Hum Genet 23:500–506PubMedCrossRef
Coman DJ, Murray D, Byrne JC et al (2010) Galactosemia, a single gene disorder with epigenetic consequences. Pediatr Res 67:286–292PubMedCrossRef
Coss KP, Byrne JC, Coman DJ et al (2012) IgG N-glycans as potential biomarkers for determining galactose tolerance in Classical Galactosaemia. Mol Genet Metab 105:212–220PubMedCrossRef
Coss KP, Doran PP, Owoeye C et al (2013) Classical Galactosaemia in Ireland: incidence, complications and outcomes of treatment. J Inherit Metab Dis 36:21–27PubMedCrossRef
Coss KP, Hawkes CP, Adamczyk B et al (2014) N-glycan abnormalities in children with galactosemia. J Proteome Res 13:385–394PubMedCrossRef
Crews C, Wilkinson KD, Wells L, Perkins C, Fridovich-Keil JL (2000) Functional consequence of substitutions at residue 171 in human galactose-1-phosphate uridylyltransferase. J Biol Chem 275:22847–22853PubMedCrossRef
Cuthbert C, Klapper H, Elsas L (2008) Diagnosis of inherited disorders of galactose metabolism. Curr Protoc Hum Genet Chapter 17:Unit 17.15
Daenzer JM, Jumbo-Lucioni PP, Hopson ML, Garza KR, Ryan EL, Fridovich-Keil JL (2016) Acute and long-term outcomes in a Drosophila melanogaster model of classic galactosemia occur independently of galactose-1-phosphate accumulation. Dis Model Mech 9:1375–1382PubMedPubMedCentralCrossRef
De Jongh S, Vreken PLIJ, Ijlst L, Wanders RJA, Jakobs CAJM, Bakker HD (1999) Spontaneous pregnancy in a patient with classical galactosaemia. JIMD 22:754–755
Decombaz J, Jentjens R, Ith M et al (2011) Fructose and galactose enhance postexercise human liver glycogen synthesis. Med Sci Sports Exerc 43:1964–1971PubMedCrossRef
De-Souza EA, Pimentel FS, Machado CM et al (2014) The unfolded protein response has a protective role in yeast models of classic galactosemia. Dis Model Mech 7:55–61PubMedCrossRef
Douglas HC, Hawthorne DC (1964) Enzymatic expression and genetic linkage of genes controlling galactose utilization in Saccharomyces. Genetics 49:837–844PubMedPubMedCentral
Douglas H, Hawthorne D (1966) Regulation of genes controlling synthesis of the galactose pathway enzymes in yeast. Genetics 54:911–916PubMedPubMedCentral
Doyle CM, Channon S, Orlowska D, Lee PJ (2010) The neuropsychological profile of galactosaemia. J Inherit Metab Dis 33:603–609PubMedCrossRef
EGS (2003) Galactosaemia in Europe - a comparison. In EGS News (European Galactosaemia Society), p 40
Elsas LJ II (2010) Galactosemia. In: Pagon R, Adam MP, Bird TD, Dolan CR, Fong C-T, Smith RJH, Stephens K (eds) Gene reviews. University of Washington, Seattle
Elsas LJ II, Dembure PP, Langley S, Paulk EM, Hjelm LN, Fridovich-Keil JL (1994) A common mutation associated with the Duarte Galactosemia allele. Am J Hum Genet 54:1030–1036PubMedPubMedCentral
Elsas LJ II, Langley S, Paulk EM, Hjelm LN, Dembure PP (1995) A molecular approach to galactosemia. Eur J Pediatr 154:S21–S27PubMedCrossRef
Elsas LJ, Lai K, Saunders CJ, Langley SD (2001) Functional analysis of the human galactose-1-phosphate uridyltransferase promoter in Duarte and LA variant galactosemia. Mol Genet Metab 72:297–305PubMedCrossRef
Facchiano A, Marabotti A (2010) Analysis of galactosemia-linked mutations of GALT enzyme using a computational biology approach. Protein Eng Des Sel 23:103–113PubMedCrossRef
Field TL, Reznikoff WS, Frey PA (1989) Galactose-1-phosphate uridylyltransferase: identification of histidine-164 and histidine-166 as critical residues by site-directed mutagenesis. Biochemistry 28:2094–2099PubMedCrossRef
Flanagan JM, Tighe O, O’ Neill C, Naughten E, Mayne PD, Croke DT (2004) Identification of sequence variation in the galactose-1-phosphate uridyl transferase gene by dHPLC. Mol Genet Metab 81:133–136PubMedCrossRef
Flanagan JM, McMahon G, Brendan Chia SH et al (2010) The role of human demographic history in determining the distribution and frequency of transferase-deficient galactosaemia mutations. Heredity (Edinb) 104:148–154CrossRef
Forges T, Monnier-Barbarino P, Leheup B, Jouvet P (2006) Pathophysiology of impaired ovarian function in galactosaemia. Hum Reprod Update 12:573–584PubMedCrossRef
Fridovich-Keil JL, Jinks-Robertson S (1993) A yeast expression system for human galactose-1-phosphate uridylyltransferase. Proc Natl Acad Sci U S A 90:398–402PubMedPubMedCentralCrossRef
Fridovich-Keil JL, Walter JH (2008) Galactosemia. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A (eds) The online metabolic and molecular bases of inherited disease. Mc-Graw Hill, New York, pp 1–92
Fridovich-Keil JL, Quimby BB, Wells L, Mazur LA, Elsevier JP (1995) Characterization of the N314D allele of human galactose-1-phosphate uridylyltransferase using a yeast expression system. Biochem Mol Med 56:121–130PubMedCrossRef
Fridovich-Keil JL, Gubbels CS, Spencer JB, Sanders RD, Land JA, Rubio-Gozalbo E (2011) Ovarian function in girls and women with GALT-deficiency galactosemia. J Inherit Metab Dis 34:357–366PubMedCrossRef
Geeganage S, Frey PA (1998) Transient kinetics of formation and reaction of the uridylyl-enzyme form of galactose-1-P uridylyltransferase and its Q168R-variant: insight into the molecular basis of galactosemia. Biochemistry 37:14500–14507PubMedCrossRef
Geeganage S, Frey PA (1999) Significance of metal ions in galactose-1-phosphate uridylyltransferase: an essential structural zinc and a nonessential structural iron. Biochemistry 38:13398–13406PubMedCrossRef
Gitzelmann R (1969) Formation of galactose-1-phosphate from uridine diphosphate galactose in erythrocytes from patients with galactosemia. Pediatr Res 3:279–286PubMedCrossRef
Gitzelmann R (1995) Galactose-1-phosphate in the pathophysiology of galactosemia. Eur J Pediatr 154:S45–S49PubMedCrossRef
Greber-Platzer S, Guldberg P, Scheibenreiter S et al (1997) Molecular heterogeneity of classical and Duarte Galactosemia: mutation analysis by denaturing gradient gel electrophoresis. Hum Mutat 10:49–57PubMedCrossRef
Gropper SS, Weese SJO, West PA, Gross KC (2000) Free galactose content of fresh fruits and strained fruit and vegetable baby foods. J Am Diet Assoc 100:573–575PubMedCrossRef
Gross KC, Acosta PB (1991) Fruits and vegetables are a source of galactose: implications in planning the diets of patients with galactosaemia. J Inherit Metab Dis 14:253–258PubMedCrossRef
Gross K, Weese S, Johnson J, Gropper S (1995) Soluble galactose content of selected baby food cereals and juices. J Food Compos Anal 8:319–323CrossRef
Gubbels CS, Land JA, Estela Rubio-Gozalbo M (2008) Fertility and impact of pregnancies on the mother and child in classic galactosemia. Obstet Gynecol Surv 63:334–343PubMedCrossRef
Gubbels CS, Kuppens SM, Bakker JA et al (2009) Pregnancy in classic galactosemia despite undetectable anti-Mullerian hormone. Fertil Steril 91(1293):e1213–e1296
Gubbels CS, Maurice-Stam H, Berry GT et al (2011) Psychosocial developmental milestones in men with classic galactosemia. J Inherit Metab Dis 34:415–419PubMedPubMedCentralCrossRef
Gubbels CS, Welt CK, Dumoulin JC et al (2013) The male reproductive system in classic galactosemia: cryptorchidism and low semen volume. J Inherit Metab Dis 36:779–786PubMedCrossRef
Haberland C, Perou M, Brunngraber EG, Hof H (1971) The neuropathology of galactosemia: a histopathological and biochemical study. J Neuropathol Exp Neurol 30:431–447PubMedCrossRef
Hansen TWR, Lie SO (1988) Galactosemia - to screen or not to screen? Pediatrics 81:327–328PubMed
Hennermann J, Schadewaldt P, Vetter B, Shin Y, Mönch E, Klein J (2011) Features and outcome of galactokinase deficiency in children diagnosed by newborn screening. J Inherit Metab Dis 34:399–407PubMedCrossRef
Hirokawa H, Okano Y, Asada M, Fujimoto A, Suyama I, Isshiki G (1999) Molecular basis for phenotypic heterogeneity in galactosaemia: prediction of clinical phenotype from genotype in Japanese patients. Eur J Hum Genet 7:757–764PubMedCrossRef
Hoffmann B, Dragano N, Schweitzer-Krantz S (2012) Living situation, occupation and health-related quality of life in adult patients with classic galactosemia. J Inherit Metab Dis 35:1051–1058PubMedCrossRef
Hughes J, Ryan S, Lambert D et al (2009) Outcomes of siblings with classical galactosemia. J Pediatr 154:721–726PubMedCrossRef
Jaeken J, Kint J, Spaapen L (1992) Serum lysosomal enzyme abnormalities in galactosaemia. Lancet 340:1472–1473PubMedCrossRef
Jensen UG, Brandt NJ, Christensen E, Skovby F, Norgaard-Pedersen B, Simonsen H (2001) Neonatal screening for galactosemia by quantitative analysis of hexose monophosphates using tandem mass spectrometry: a retrospective study. Clin Chem 47:1364–1372PubMed
Jumbo-Lucioni PP, Garber K, Kiel J et al (2012) Diversity of approaches to classic galactosemia around the world: a comparison of diagnosis, intervention, and outcomes. J Inherit Metab Dis 35:1037–1049PubMedPubMedCentralCrossRef
Jumbo-Lucioni PP, Parkinson W, Broadie K (2014a) Overelaborated synaptic architecture and reduced synaptomatrix glycosylation in a Drosophila classic galactosemia disease model. Dis Model Mech
Jumbo-Lucioni PP, Ryan EL, Hopson ML et al (2014a) Manganese-based superoxide dismutase mimics modify both acute and long-term outcome severity in a Drosophila melanogaster model of classic galactosemia. Antioxid Redox Signal 20:2361–2371PubMedPubMedCentralCrossRef
Jumbo-Lucioni PP, Parkinson WM, Kopke DL, Broadie K (2016) Coordinated movement, neuromuscular synaptogenesis and trans-synaptic signaling defects in Drosophila galactosemia models. Hum Mol Genet
Karadag N, Zenciroglu A, Eminoglu FT et al (2013) Literature review and outcome of classic galactosemia diagnosed in the neonatal period. Clin Lab 59:1–8CrossRef
Kaufman F, Kogut M, Donnell G, Goebelsmann U, March C, Koch R (1981) Hypergonadotropic hypogonadism in female patients with galactosemia. New Engl J Med 304:994–998PubMedCrossRef
Kaufman FR, Loro ML, Azen C, Wenz E, Gilsanz V (1993) Effect of hypogonadism and deficient calcium intake on bone density in patients with galactosemia. J Pediatr 123:365–370PubMedCrossRef
Kaufman FR, McBride-Chang C, Manis FR, Wolff J, Nelson L (1995) Cognitive functioning, neurologic status and brain imaging in classical galactosemia. Eur J Pediatr 154:S2–S5PubMedCrossRef
Kim H, Hartnett C, Scaman C (2007) Free galactose content in selected fresh fruits and vegetables and soy beverages. J Agric Food Chem 55:8133–8137PubMedCrossRef
Kimonis V (2001) Increased fertility in a woman with classic galactosaemia. JIMD 24:507–608
Koch TK, Schmidt KA, Wagstaff JE, Ng WG, Packman S (1992) Neurologic complications in galactosemia. Pediatr Neurol 8:217–220PubMedCrossRef
Kozak L, Francova H (1999) Presence of a deletion in the 5′ upstream region of the GALT gene in Duarte (D2) alleles. J Med Genet 36:576–578PubMedPubMedCentral
Kozák L, Francová H, Fajkusová L et al (1999) Mutation analysis of the GALT gene in Czech and Slovak galactosemia populations: identification of six novel mutations, including a stop codon mutation (X380R). Hum Mutat 15:1–8
Krabbi K, Uudelepp ML, Joost K, Zordania R, Ounap K (2011) Long-term complications in Estonian galactosemia patients with a less strict lactose-free diet and metabolic control. Mol Genet Metab 103:249–253PubMedCrossRef
Lai K, Elsas LJ (2001) Structure-function analyses of a common mutation in blacks with transferase-deficiency galactosemia. Mol Genet Metab 74:264–272PubMedCrossRef
Lai K, Klapa MI (2004) Alternative pathways of galactose assimilation: could inverse metabolic engineering provide an alternative to galactosemic patients? Metab Eng 6:239–244PubMedCrossRef
Lai K, Langley SD, Singh RH, Dembure PP, Hjelm LN, Elsas LJ II (1996) A prevalent mutation for galactosemia among black Americans. J Pediatr 128:89–95PubMedCrossRef
Lai K, Willis AC, Elsas LJ II (1999) The biochemical role of glutamine 188 in human galactose-1-phosphate uridyltransferase. J Biol Chem 274:6559–6566PubMedCrossRef
Lai K, Langley SD, Khwaja FW, Schmitt EW, Elsas LJ (2003a) GALT deficiency causes UDP-hexose deficit in human galactosemic cells. Glycobiology 13:285–294PubMedCrossRef
Lai KW, Cheng LY, Cheung AL, WS O (2003b) Inhibitor of apoptosis proteins and ovarian dysfunction in galactosemic rats. Cell Tissue Res 311:417–425PubMed
Langley SD, Lai K, Dembure PP, Hjelm LN, Elsas LJ II (1997) Molecular basis for Duarte and Los Angeles variant galactosemia. Am J Hum Genet 60:366–372PubMedPubMedCentral
Lebea PJ, Pretorius PJ (2005) The molecular relationship between deficient UDP-galactose uridyl transferase (GALT) and ceramide galactosyltransferase (CGT) enzyme function: a possible cause for poor long-term prognosis in classic galactosemia. Med Hypotheses 65:1051–1057PubMedCrossRef
Leslie ND, Immerrman EB, Flach JE, Florez M, Fridovich-Keil JL, Elsas LJ II (1992) The human galactose-1-phosphate uridyltransferase gene. Genomics 14:474–480PubMedCrossRef
Leslie ND, Yager KL, McNamara PD, Segal S (1996) A mouse model of galactose-1-phosphate uridyl transferase deficiency. Biochem Mol Med 59:7–12PubMedCrossRef
Levy H (1996) Reproductive effects of maternal metabolic disorders: implications for pediatrics and obstetrics. Turk J Pediatr 38:335–344PubMed
Levy H, Driscoll S, Porensky R, Wender D (1984) Ovarian failure in galactosaemia. N Engl J Med 310:50
Lewis M (2011) The measurement and significance of ionic calcium in milk–a review. Int J Dairy Technol 64:1–3CrossRef
Lindhout M, Rubio-Gozalbo ME, Bakker JA, Bierau J (2010) Direct non-radioactive assay of galactose-1-phosphate:uridyltransferase activity using high performance liquid chromatography. Clin Chim Acta 411:980–983PubMedCrossRef
Liu G, Hale GE, Hughes CL (2000) Galactose metabolism and ovarian toxicity. Reprod Toxicol 14:377–384PubMedCrossRef
Liu L, Tang M, Walsh MJ et al (2015) Structure activity relationships of human galactokinase inhibitors. Bioorg Med Chem Lett 25:721–727PubMedCrossRef
Lo W, Packman S, Nash S et al (1984) Curious neurologic sequelae in galactosemia. Pediatrics 73:309–312PubMed
Lu J, Wu DM, Zheng YL, Hu B, Zhang ZF (2010) Purple sweet potato color alleviates d‐galactose‐induced brain aging in old mice by promoting survival of neurons via PI3K pathway and inhibiting cytochrome c‐mediated apoptosis. Brain Pathol 20:598–612PubMedCrossRef
Lukac-Bajalo J, Kuzelicki NK, Zitnik IP, Mencej S, Battelino T (2007) Higher frequency of the galactose-1-phosphate uridyl transferase gene K285N mutation in the Slovenian population. Clin Biochem 40:414–415PubMedCrossRef
Lund AM, Hougaard DM, Simonsen H et al (2012) Biochemical screening of 504,049 newborns in Denmark, the Faroe Islands and Greenland—experience and development of a routine program for expanded newborn screening. Mol Genet Metab 107:281–293
Manga N, Jenkins T, Jackson H, Whittaker DA, Lane AB (1999) The molecular basis of transferase galactosaemia in South African negroids. J Inherit Metab Dis 22:37–42PubMedCrossRef
Manis FR, Cohn LB, McBride-Chang C, Wolff J, Kaufman FR (1997) A longitudinal study of cognitive functioning in patients with classical galactosaemia, including a cohort treated with oral uridine. J Inherit Metab Dis 20:549–555PubMedCrossRef
Marabotti A, Facchiano A (2005) Homology modeling studies on human galactose-1-phosphate uridylyltransferase and on its galactosemia-related mutant Q188R provide an explanation of molecular effects of the mutation on homo-and heterodimers. J Med Chem 48:773–779PubMedCrossRef
Maratha A, Stockmann H, Coss KP et al (2016) Classical galactosaemia: novel insights in IgG N-glycosylation and N-glycan biosynthesis. Eur J Hum Genet 24:976-84
McCorvie TJ, Gleason TJ, Fridovich-Keil JL, Timson DJ (2013) Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia. Biochim Biophys Acta 1832:1279–1293PubMedPubMedCentralCrossRef
McCorvie T, Kopec J, Pey A et al (2016) Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase. Hum Mol Genet 25:2234–2244PubMedPubMedCentralCrossRef
Mumma JO, Chhay JS, Ross KL, Eaton JS, Newell-Litwa KA, Fridovich-Keil JL (2008) Distinct roles of galactose-1P in galactose-mediated growth arrest of yeast deficient in galactose-1P uridylyltransferase (GALT) and UDP-galactose 4′-epimerase (GALE). Mol Genet Metab 93:160–171PubMedCrossRef
Nelson MD, Wolff JA, Cross CA, Donnel GN, Kaufman FR (1992) Galactosemia: evaluation with MR imaging. Radiology 184:255–261PubMedCrossRef
Ng WG, Bergren WR, Donnel GN (1973) A new variant of galactose-1-phosphate uridyltransferase in man: the Los Angeles variant. Ann Hum Genet 37:1–8CrossRef
Ng DT, Xu YK, Kaufman FR, Donnel GN (1989) Deficit of uridine diphosphate galactose in galactosaemia. J Inherit Metab Dis 12:257–266PubMedCrossRef
Ning C, Segal S (2000) Plasma galactose and galactitol concentration in patients with galactose-1-phosphate uridyltransferase deficiency galactosemia: determination by gas chromatography/mass spectrometry. Metabolism 49:1460–1466PubMedCrossRef
Ning C, Fenn PT, Blair IA, Berry GT, Segal S (2000) Apparent galactose appearance rate in human galactosemia based on plasma [13C]galactose isotopic enrichment. Mol Genet Metab 70:261–271PubMedCrossRef
Odejinmi S, Rascon R, Tang M, Vankayalapati H, Lai K (2011) Structure-activity analysis and cell-based optimization of human galactokinase inhibitors. ACS Med Chem Lett 2:667–672PubMedPubMedCentralCrossRef
Ohlsson A, Nasiell J, von Dobeln U (2007) Pregnancy and lactation in a woman with classical galactosaemia heterozygous for p.Q188R and p.R333W. J Inherit Metab Dis 30:105PubMedCrossRef
Ohlsson A, Guthenberg C, von Döbeln U (2012) Galactosemia screening with low false-positive recall rate: the Swedish experience. J Inherit Metab Dis Rep Case Res Rep 2:113–117
Palmieri M, Mazur A, Berry G et al (1999) Urine and plasma galactitol in patients with galactose-1-phosphate uridyltransferase deficiency galactosemia. Metabolism 48:1294–1302PubMedCrossRef
Panis B, Forget PP, van Kroonenburgh MJ et al (2004) Bone metabolism in galactosemia. Bone 35:982–987PubMedCrossRef
Panis B, Forget PP, Nieman FH, van Kroonenburgh MJ, Rubio-Gozalbo ME (2005) Body composition in children with galactosaemia. J Inherit Metab Dis 28:931–937PubMedCrossRef
Panis B, Vermeer C, van Kroonenburgh MJ et al (2006) Effect of calcium, vitamins K1 and D3 on bone in galactosemia. Bone 39:1123–1129PubMedCrossRef
Panis B, Gerver WJ, Rubio-Gozalbo ME (2007) Growth in treated classical galactosemia patients. Eur J Pediatr 166:443–446PubMedCrossRef
Petry KG (1991) Characterization of a novel biochemical abnormality in galactosemia: deficiency of glycolipids containing galactose or N-acetylgalactosamine and accumulation of precursors in brain and lymphocytes. Biochem Med Metab Biol 46
Pintor J (2012) Sugars, the crystalline lens and the development of cataracts. Biochem Pharmacol 1:e119
Podskarbi T, Kohlmetz T, Gathof BS et al (1996) Molecular characterization of Duarte-1 and Duarte-2 variants of galactose-l-phosphate uridyltransferase. J Inherit Metab Dis 19:638–644PubMedCrossRef
Pollitt RJ, Green A, McCabe CJ et al (1997) Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technol Assess Rep 1:1–202
Portnoi PA, MacDonald A (2009). Determination of the lactose and galactose content of cheese for use in the galactosaemia diet. J Hum Nutr Diet 22:400-408
Portnoi PA, Macdonald A (2011). The lactose content of Mini Babybel and suitability for galactosaemia. J Hum Nutr Diet 24:620-621
Portnoi PA, Macdonald A (2016). The lactose and galactose content of cheese suitable for galactosaemia: new analysis. JIMD Reports, 29:85-87
Potter NL (2011) Voice disorders in children with classic galactosemia. J Inher Metab Dis 34:377–385PubMedCrossRef
Potter NL, Lazarus JA, Johnson JM, Steiner RD, Shriberg LD (2008) Correlates of language impairment in children with galactosaemia. J Inherit Metab Dis 31:524–532PubMedPubMedCentralCrossRef
Quan-Ma R, Wells HJ, Wells WW, Sherman FE, Egan TJ (1966) Galactitol in the tissues of a galactosemic child. Am J Dis Child 112:477–478PubMed
Reichardt JK (1991) Molecular basis of galactosemia: Mutations and polymorphisms in the gene encoding human galactose-1-phosphate uridylyltransferase. Proc Natl Acad Sci U S A
Riehman K, Crews C, Fridovich-Keil JL (2001) Relationship between genotype, activity, and galactose sensitivity in yeast expressing patient alleles of human galactose-1-phosphate uridylyltransferase. J Biol Chem 276:10634–10640PubMedCrossRef
Robertson A, Singh RH, Guerrero NV, Hundley M, Elsas LJ II (2000) Outcomes analysis of verbal dyspraxia in classic galactosemia. Genet Med 2:142–148PubMedCrossRef
Roe TF, Hallatt JG, Donnell GN, Ng WG (1971) Childbearing by a galactosemic woman. Eur J Pediatr 78:1026–1030CrossRef
Ross KL, Davis CN, Fridovich-Keil JL (2004) Differential roles of the Leloir pathway enzymes and metabolites in defining galactose sensitivity in yeast. Mol Genet Metab 83:103–116PubMedCrossRef
Rubio-Gozalbo ME, Panis B, Zimmermann LJ, Spaapen LJ, Menheere PP (2006) The endocrine system in treated patients with classical galactosemia. Mol Genet Metab 89:316–322PubMedCrossRef
Rubio-Gozalbo ME, Gubbels CS, Bakker JA, Menheere PP, Wodzig WK, Land JA (2010) Gonadal function in male and female patients with classic galactosemia. Hum Reprod Update 16:177–188PubMedCrossRef
Rubio-Gozalbo ME, Bosch AM, Burlina A, Berry GT, Treacy EP, Steering Committee on behalf of all Galactosemia Network representatives (2016) The galactosemia network (GalNet). J Inherit Metab Dis 40:169-170
Samuels S, Sun SC, Verasestakul S (1976) Normal infant birth in white galactosemic woman. J Med Soc 73:309–311
Sanders RD, Spencer JB, Epstein MP et al (2009) Biomarkers of ovarian function in girls and women with classic galactosemia. Fertil Steril 92:344–351PubMedCrossRef
Schadewaldt P (2004) Age dependence of endogenous galactose formation in Q188R homozygous galactosemic patients. Mol Genet Metab 81:31–44PubMedCrossRef
Schadewaldt P, Kamalanathan L, Hammen HW, Wendel U (2003) Stable-isotope dilution analysis of galactose metabolites in human erythrocytes. Rapid Commun Mass Spectrom 17:2833–2838PubMedCrossRef
Schadewaldt P, Kamalanathan L, Hammen H-W, Kotzka J, Wendel U (2014) Endogenous galactose formation in galactose-1-phosphate uridyltransferase deficiency. Arch Physiol Biochem 120:228–239PubMedCrossRef
Schweitzer S, Shin Y, Jakobs C, Brodehl J (1993) Long-term outcome in 134 patients with galactosaemia. Eur J Pediatr 152:36–43PubMedCrossRef
Shah V, Friedman S, Moore AM, Platt BA, Feigenbaum ASJ (2001) Selective screening for neonatal galactosemia: an alternative approach. Acta Paediatr 90:948–949PubMedCrossRef
Singh R, Thapa BR, Kaur G, Prasad R (2012) Frequency distribution of Q188R, N314D, Duarte 1, and Duarte 2 GALT variant alleles in an Indian galactosemia population. Biochem Genet 50:871–880PubMedCrossRef
Slepak T, Tang M, Addo F, Lai K (2005) Intracellular galactose-1-phosphate accumulation leads to environmental stress response in yeast model. Mol Genet Metab 86:360–371PubMedCrossRef
Spencer JB, Badik JR, Ryan EL et al (2013) Modifiers of ovarian function in girls and women with classic galactosemia. J Clin Endocrinol Metab 98:E1257–E1265PubMedPubMedCentralCrossRef
Sturiale L, Barone R, Fiumara A et al (2005) Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia. Glycobiology 15:1268–1276PubMedCrossRef
Suzuki M, West C, Beutler E (2001) Large-scale molecular screening for galactosemia alleles in a pan-ethnic population. Hum Genet 109:210–215PubMedCrossRef
Tang M, Wierenga K, Elsas LJ, Lai K (2010) Molecular and biochemical characterization of human galactokinase and its small molecule inhibitors. Chem Biol Interact 188:376–385PubMedCrossRef
Tang M, Odejinmi SI, Vankayalapati H, Wierenga KJ, Lai K (2012) Innovative therapy for classic galactosemia - tale of two HTS. Mol Genet Metab 105:44–55PubMedCrossRef
Tang M, Siddiqi A, Witt B et al (2014) Subfertility and growth restriction in a new galactose-1 phosphate uridylyltransferase (GALT) - deficient mouse model. Eur J Hum Genet
Tedesco TA, Morrow G, Mellman WJ (1972) Normal pregnancy and childbirth in a galactosemic woman. Eur J Pediatr 81:1159–1161CrossRef
Thoden JB, Ruzicka FJ, Frey PA, Rayment I, Holden HM (1997) Structural analysis of the H166G site-directed mutant of galactose-1-phosphate uridylyltransferase complexed with either UDP-glucose or UDP-galactose: detailed description of the nucleotide sugar binding site. Biochemistry 36:1212–1222PubMedCrossRef
Timmers I, van den Hurk J, Di Salle F, Rubio-Gozalbo ME, Jansma BM (2011) Language production and working memory in classic galactosemia from a cognitive neuroscience perspective: future research directions. J Inherit Metab Dis 34:367–376PubMedPubMedCentralCrossRef
Timmers I, Jansma BM, Rubio-Gozalbo ME (2012) From mind to mouth: event related potentials of sentence production in classic galactosemia. PLoS One 7:e52826PubMedPubMedCentralCrossRef
Timmers I, Hurk Jvd, Hofman PA et al (2015) Affected functional networks associated with sentence production in classic galactosemia. Brain Res 1616:166-176
Timmers I, Zhang H, Bastiani M, Jansma BM, Roebroeck A, Rubio-Gozalbo E (2015b) Assessing white matter microstructure in classic galactosemia using neurite orientation dispersion and density imaging. J Inherit Metab Dis 38:295–304PubMedCrossRef
Timson DJ (2014) Purple sweet potato colour—a potential therapy for galactosemia? Int J Food Sci Nutr 65:391–393
Timson DJ, Reece RJ (2003) Identification and characterisation of human aldose 1-epimerase. FEBS Lett 543:21–24PubMedCrossRef
Trbušek M, Francova H, Kozak L (2001) Galactosemia: deletion in the 5′ upstream region of the GALT gene reduces promoter efficiency. Hum Genet 109:117–120PubMedCrossRef
Van Calcar S, Bernstein L, Rohr F, Scaman C, Yannicelli S, Berry G (2014a) A re-evaluation of life-long severe galactose restriction for the nutrition management of classic galactosemia. Mol Genet Metab 112:191–197PubMedCrossRef
Van Calcar S, Bernstein L, Rohr F, Yannicelli S, Berry G, Scaman C (2014b) Galactose content of legumes, caseinates, and some hard cheeses: implications for diet treatment of classic galactosemia. J Agric Food Chem 62:1397–1402PubMedCrossRef
Wadelius C, Lagerkvist A, Molin A-K, Larsson A, Doebeln UV (1993) Galactosemia caused by a point mutation that activates cryptic donor splice site in the galactose-1-phosphate uridyltransferase gene. Genomics 17:525–526PubMedCrossRef
Waggoner DD, Buist NRM, Donnel GN (1990) Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inherit Metab Dis 13:802–818PubMedCrossRef
Waisbren SE, Norman TR, Schnell RR, Levy HL (1983) Speech and language deficits in early-treated children with galactosemia. J Pediatr 102:75–77PubMedCrossRef
Waisbren SE, Read CY, Ampola M et al (2002) Newborn screening compared to clinical identification of biochemical genetic disorders. J Inherit Metab Dis 25:599–600PubMedCrossRef
Waisbren SE, Potter NL, Gordon CM et al (2012) The adult galactosemic phenotype. J Inherit Metab Dis 35:279–286PubMedCrossRef
Wang ZJ, Berry GT, Dreha SF, Zhao H, Segal S, Zimmerman RA (2001) Proton magnetic resonance spectroscopy of brain metabolites in galactosemia. Ann Neurol 50:266–269PubMedCrossRef
Wedekind JE, Frey PA, Rayment I (1995) Three-dimensional structure of galactose-1-phosphate uridylyltransferase from Escherichia coli at 1.8 Å resolution. Biochemistry 34:11049–11061PubMedCrossRef
Wedekind JE, Frey PA, Rayment I (1996) The structure of nucleotidylated histidine-166 of galactose-1-phosphate uridylyltransferase provides insight into phosphoryl group transfer. Biochemistry 35:11560–11569PubMedCrossRef
Wehrli SL, Berry GT, Palmieri M, Mazur A, Elsas LJ II, Segal S (1997) Urinary galactonate in patients with galactosemia: quantitation by nuclear magnetic resonance spectroscopy. Pediatr Res 42:855–861PubMedCrossRef
Welling L, Bernstein LE, Berry GT et al (2016) International clinical guideline for the management of classical galactosemia: diagnosis, treatment, and follow-up. J Inherit Metab Dis 40:171-176
Wells L, Fridovich-Keil JL (1997) Biochemical characterization of the S135L allele of galactose-1-phosphate uridylyltransferase associated with galactosaemia. J Inherit Metab Dis 20:633–642PubMedCrossRef
Wong L-J, Frey PA (1974a) Galactose-1-phosphate uridylyltransferase Isolation of a uridylyl-enzyme intermediate. J Biol Chem 249:2322–2324PubMed
Wong L-J, Frey PA (1974b) Galactose-1-phosphate uridylyltransferase. Rate studies confirming a uridylyl-enzyme intermediate on the catalytic pathway. Biochemistry 13:3889–3894PubMedCrossRef
Wood IS, Trayhurn P (2003) Glucose transporters (GLUT and SGLT): expanded families of sugar transport proteins. Br J Nutr 89:3–9PubMedCrossRef
Yager CT, Chen J, Reynolds R, Segal S (2003) Galactitol and galactonate in red blood cells of galactosemic patients. Mol Genet Metab 80:283–289PubMedCrossRef
Yager C, Wehrli S, Segal S (2006) Urinary galactitol and galactonate quantified by isotope-dilution gas chromatography–mass spectrometry. Clin Chim Acta 366:216–224PubMedCrossRef
Zekanowski C, Radomyska B, Bal J (1999) Molecular characterization of Polish patients with classical galactosaemia. J Inherit Metab Dis 22:679–682PubMedCrossRef
Zhang ZF, Lu J, Zheng YL et al (2010) Purple sweet potato color protects mouse liver against D-galactose-induced apoptosis via inhibiting caspase-3 activation and enhancing PI3K/Akt pathway. Food Chem Toxicol 48:2500–2507PubMedCrossRef
Metadata
Title
Sweet and sour: an update on classic galactosemia
Authors
Ana I. Coelho
M. Estela Rubio-Gozalbo
João B. Vicente
Isabel Rivera
Publication date
01-05-2017
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 3/2017
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-017-0029-3

Other articles of this Issue 3/2017

Journal of Inherited Metabolic Disease 3/2017 Go to the issue

Original Article

Expanding the phenotype in argininosuccinic aciduria: need for new therapies

Original Article

Disturbed iron metabolism in erythropoietic protoporphyria and association of GDF15 and gender with disease severity

Original Article

Mild orotic aciduria in UMPS heterozygotes: a metabolic finding without clinical consequences

Original Article

Slow, continuous enzyme replacement via spinal CSF in dogs with the paediatric-onset neurodegenerative disease, MPS IIIA

Original Article

Neurocognitive profiles in MSUD school-age patients

Letter to the Editors

Losartan improves aortic dilatation and cardiovascular disease in mucopolysaccharidosis I
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits